Preeclampsia occurs more frequently in women of African ancestry. The cause of this hypertensive complication is unclear, but placental oxidative stress may play a role. Because mitochondria are the major sites of oxidative phosphorylation, we hypothesized that placentas of preeclamptic pregnancies harbor mitochondrial DNA (mtDNA) mutations. Next-generation sequencing of placental mtDNA in African American preeclamptics (N = 30) and controls (N = 38) from Chicago revealed significant excesses in preeclamptics of nonsynonymous substitutions in protein-coding genes and mitochondrially encoded nicotinamide adenine dinucleotide dehydrogenase 5 gene and an increase in the substitution rate (P = .0001). Moreover, 88% of preeclamptics and 53% of controls carried at least one nonsynonymous substitution (P = .005; odds ratio [OR] = 6.36, 95% confidence interval [CI]: 1.5-39.1). These results were not replicated in a sample of African American preeclamptics (N = 162) and controls (N = 171) from Detroit. Differences in study design and heterogeneity may account for this lack of replication. Nonsynonymous substitutions in mtDNA may be risk factors for preeclampsia in some African American women, but additional studies are required to establish this relationship.
NessRRobertsJ. Epidemiology of pregnancy-related hypertension. In: LindheimerMRobertsJCunninghamF, eds. Chesley’s Hypertensive Disorders in Pregnancy. 3 rd ed. San Diego, CA: Academic Press; 2009:37–50.
2.
VillarJSayLGulmezohluAEclampsia and preeclampsia: a worldwide health problem for 2000 years. In: CritchleyHMacleanAPostonLWalkerJ, eds. Preeclampsia. RCOG Press; 2003:189–207.
3.
SamadiAMayberryRZaidiAMaternal hypertension and associated pregnancy complications among African-American and other women in the United States. Obstet Gynecol. 1996;87(4):557–563.
4.
CaugheyABStotlandNEWashingtonAEEscobarGJ. Maternal ethnicity, paternal ethnicity, and parental ethnic discordance: predictors of preeclampsia. Obstet Gynecol. 2005;106(1):156–161.
5.
TanakaMJaamaaGKaiserMRacial disparity in hypertensive disorders of pregnancy in New York State: a 10-year longitudinal population-based study. Am J Public Health. 2006;97(1):163–170.
6.
RobertsJMRedmanCW. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet. 1993;341(8858):1447–1451.
7.
RedmanCW. Current topic: pre-eclampsia and the placenta. Placenta. 1991;12(4):301–308.
8.
WangZZhangGLinM. Mitochondrial tRNA(leu)(UUR) gene mutation and the decreased activity of cytochrome c oxidase in preeclampsia. J Tongji Med Univ. 1999;19(3):209–211.
9.
WangY. Placental mitochondria as a source of oxidative stress in pre-eclampsia. Placenta. 1998;19(8):581–586.
10.
WangYWalshSWKayHH. Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia. Am J Obstet Gynecol. 1992;167(4 pt 1):946–949.
11.
GuptaSAgarwalASharmaRK. The role of placental oxidative stress and lipid peroxidation in preeclampsia. Obstet Gynecol Surv. 2005;60(12):807–816.
12.
BalabanRSNemotoSFinkelT. Mitochondria, oxidants, and aging. Cell. 2005;120(4):483–495.
BerkowitzKMonteagudoAMarksFJacksonUBaxiL. Mitochondrial myopathy and preeclampsia associated with pregnancy. Am J Obstet Gynecol. 1990;162(1):146–147.
15.
FolgerøTStorbakkNTorbergsenTOianP. Mutations in mitochondrial transfer ribonucleic acid genes in preeclampsia. Am J Obstet Gynecol. 1996;174(5):1626–1630.
16.
JauniauxEPostonLBurtonGJ. Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution. Hum Reprod Update. 2006;12(6):747–755.
17.
ShanklinDRSibaiBM. Ultrastructural aspects of preeclampsia. II. Mitochondrial changes. Am J Obstet Gynecol. 1990;163(3):943–953.
18.
WidschwendterMSchrocksnadelHMortlM. Pre-eclampsia: a disorder of placental mitochondria?Mol Med Today. 1998;4(7):286–291.
19.
DiMauroSSchonEA. Mitochondrial respiratory-chain diseases. N Engl J Med. 2003;348(26):2656–2668.
20.
VuorinenKRemesASormunenRTapanainenJHassinenIE. Placental mitochondrial DNA and respiratory chain enzymes in the etiology of preeclampsia. Obstet Gynecol. 1998;91(6):950–955.
21.
MetzkerML. Sequencing technologies—the next generation. Nat Rev Genet. 2010;11(1):31–46.
22.
LindheimerMDTalerSJCunninghamFG. Hypertension in pregnancy. J Am Soc Hypertens. 2010;4(2):68–78.
23.
Anon. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183(1):S1–S22.
24.
LangmeadBTrapnellCPopMSalzbergSL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009;10(3):R25.
25.
CannRLStonekingMWilsonAC. Mitochondrial DNA and human evolution. Nature. 1987;325(6099):31–36.
26.
van OvenMKayserM. Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum Mutat. 2009;30(2):E386–394.
27.
BeharDMVillemsRSoodyallHThe Dawn of Human Matrilineal Diversity. Am J Hum Genet. 2008;82(5):1130–1140.
28.
SalasARichardsMLareuM-VThe African diaspora: mitochondrial DNA and the Atlantic slave trade. Am J Hum Genet. 2004;74(3):454–465.
29.
GonderMKMortensenHMReedFAde SousaATishkoffSA. Whole-mtDNA genome sequence analysis of ancient African lineages. Mol Biol Evol. 2006;24(3):757–768.
30.
EltsovNVolodkoNStarikovskayaESukernikR. New tool (mtPHYL) proposed for phylogenetic analysis of human complete mitochondrial genomes. http://eltsov.org/mtphyl.aspx. Accessed February 2, 2011.
31.
IngmanMGyllenstenU. Analysis of the complete human mtDNA genome: methodology and inferences for human evolution. J Hered. 2001;92(6):454–461.
32.
AlexanderGRHimesJHKaufmanRBMorJKoganM. A United States national reference for fetal growth. Obstet Gynecol. 1996;87(2):163–168.
33.
PichlerIFuchsbergerCPlatzerCDrawing the history of the Hutterite population on a genetic landscape: inference from Y-chromosome and mtDNA genotypes. Eur J Hum Genet. 2009;18(4):463–470.
34.
ChaiworapongsaTRomeroREspinozaJEvidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol. 2004;190(6):1541–1547; discussion 1547-1550.
35.
KusanovicJPRomeroRJodickeCAmniotic fluid soluble human leukocyte antigen-G in term and preterm parturition, and intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med. 2009;22(12):1151–1166.
36.
LevineRJLamCQianCSoluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355(10):992–1005.
37.
RomeroRChaiworapongsaTErezOAn imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study. J Matern Fetal Neonatal Med2010;23(12):1384–1399.
38.
RomeroRNienJKEspinozaJA longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 2008;21(1):9–23.
39.
LiuX-LZhouXZhouJLeber’s hereditary optic neuropathy is associated with the T12338C mutation in mitochondrial ND5 gene in six Han Chinese families. Ophthalmology. 2010. http://www.ncbi.nlm.nih.gov/pubmed/21131053
40.
ZouYJiaXZhangA-MThe MT-ND1 and MT-ND5 genes are mutational hotspots for Chinese families with clinical features of LHON but lacking the three primary mutations. Biochem Biophys Res Commun. 2010;399(2):179–185.
41.
LiolitsaDRahmanSBentonSCarrLJHannaMG. Is the mitochondrial complex I ND5 gene a hot-spot for MELAS causing mutations?Ann Neurol. 2003;53(1):128–132.
42.
ShanskeSCokuJLuJThe G13513A mutation in the ND5 gene of mitochondrial DNA as a common cause of MELAS or Leigh syndrome: evidence from 12 cases. Arch Neurol. 2008;65(3):368–372.
43.
BaiYShakeleyRMAttardiG. Tight control of respiration by NADH dehydrogenase ND5 subunit gene expression in mouse mitochondria. Mol Cell Biol. 2000;20(3):805–815.
44.
BrownWMGeorgeMJr, WilsonAC. Rapid evolution of animal mitochondrial DNA. Proc Natl Acad Sci U S A. 1979;76(4):1967–1971.
45.
FayJCWuCI. A human population bottleneck can account for the discordance between patterns of mitochondrial versus nuclear DNA variation. Mol Biol Evol. 1999;16(7):1003–1005.
46.
SigurõardóttirSHelgasonAGulcherJRStefanssonKDonnellyP. The mutation rate in the human mtDNA control region. Am J Hum Genet. 2000;66(5):1599–1609.
47.
ChenYSTorroniAExcoffierLSantachiara-BenerecettiASWallaceDC. Analysis of mtDNA variation in African populations reveals the most ancient of all human continent-specific haplogroups. Am J Hum Genet. 1995;57(1):133–149.
48.
IngmanMKaessmannHPääboSGyllenstenU. Mitochondrial genome variation and the origin of modern humans. Nature. 2000;408(6813):708–713.
49.
ParraEJMarciniAAkeyJEstimating African American admixture proportions by use of population-specific alleles. Am J Hum Genet. 1998;63(6):1839–1851.
50.
ZakhariaFBasuAAbsherDCharacterizing the admixed African ancestry of African Americans. Genome Biol. 2009;10(12):R141.
51.
ChevrollierAGuilletVLoiseauDHereditary optic neuropathies share a common mitochondrial coupling defect. Ann Neurol. 2008;63(6):794–798.
52.
SantorelliFMShanskeSMacayaADeVivoDCDiMauroS. The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh’s syndrome. Ann Neurol. 1993;34(6):827–834.
BuXDRotterJI. X chromosome-linked and mitochondrial gene control of Leber hereditary optic neuropathy: evidence from segregation analysis for dependence on X chromosome inactivation. Proc Natl Acad Sci U S A. 1991;88(18):8198–8202.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
